CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 5,000 shares of BMRN on 01/18/2013 at an average price of $54 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $6.81 billion; its shares were traded at around $54.79 with and P/S ratio of 13.5.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.

CEO Recent Trades:

• CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 01/18/2013 at the average price of 54. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 1.46% since.
• CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 01/04/2013 at the average price of 52.24. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 4.88% since.
• CEO Jean Jacques Bienaime sold 5,000 shares of BMRN stock on 12/31/2012 at the average price of 48.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 12.69% since.
• CEO Jean Jacques Bienaime sold 17,000 shares of BMRN stock on 12/27/2012 at the average price of 48.37. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 13.27% since.
• CEO Jean Jacques Bienaime sold 9,000 shares of BMRN stock on 12/21/2012 at the average price of 48.57. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 12.81% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.

Directors and Officers Recent Trades:

• EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 01/03/2013 at the average price of 53. Robert Baffi owns at least 100,413 shares after this. The price of the stock has increased by 3.38% since.
• Director Richard A Meier sold 10,000 shares of BMRN stock on 01/02/2013 at the average price of 51.25. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 6.91% since.
• VP, Human Resources Mark Wood sold 10,415 shares of BMRN stock on 12/17/2012 at the average price of 49.17. Mark Wood owns at least 25,646 shares after this. The price of the stock has increased by 11.43% since.
• Director Richard A Meier sold 5,000 shares of BMRN stock on 12/11/2012 at the average price of 49.71. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 10.22% since.
• Director Richard A Meier sold 5,000 shares of BMRN stock on 11/29/2012 at the average price of 49.17. Richard A Meier owns at least 18,650 shares after this. The price of the stock has increased by 11.43% since.

For the complete insider trading history of BMRN, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool